Other monoclonal antibodies and antibody drug conjugates
- ATC Codes
- Antineoplastic and immunomodulating agents
- Antineoplastic drugs
- Monoclonal Antibodies and Antibody Drug Conjugates
- Other monoclonal antibodies and antibody drug conjugates
- L01FX01 : Edrecolomab
- L01FX02 : Gemtuzumab ozogamicin
- L01FX03 : Catumaxomab
- L01FX04 : Ipilimumab
- L01FX05 : Brentuximab vedotin
- L01FX06 : Dinutuximab beta
- L01FX07 : Blinatumomab
- L01FX08 : Elotuzumab
- L01FX09 : Mogamulizumab
- L01FX10 : Olaratumab
- L01FX11 : Bermekimab
- L01FX12 : Tafasitamab
- L01FX13 : Enfortumab vedotin
- L01FX14 : Polatuzumab vedotin
- L01FX15 : Belantamab mafodotin
- L01FX16 : Oportuzumab monatox
- L01FX17 : Sacituzumab govitecan
- L01FX18 : Amivantamab